• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Clarivate Plc (Amendment)

    2/14/24 11:18:01 AM ET
    $CLVT
    EDP Services
    Technology
    Get the next $CLVT alert in real time by email
    SC 13G/A 1 generation-clvt123123a2.htm



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549

     

    SCHEDULE 13G/A 

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)* 


     

    CLARIVATE PLC
    (Name of Issuer)

     

     

    Ordinary Shares, no par value
    (Title of Class of Securities)

     

     

    G21810109

    (CUSIP Number)

     

     

    December 31, 2023
    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    o Rule 13d-1(b)

    x Rule 13d-1(c)

    o Rule 13d-1(d)

     

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     

     

    CUSIP No. G21810109
     SCHEDULE 13G/A
    Page 2 of 11 Pages
             
    1
    NAME OF REPORTING PERSONS
     
    Generation Investment Management LLP
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    England and Wales
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    190,085
    6
    SHARED VOTING POWER
     
    28,587,066
    7
    SOLE DISPOSITIVE POWER
     
    190,085
    8
    SHARED DISPOSITIVE POWER
     
    29,160,869
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    29,350,954
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    4.42%
    12
    TYPE OF REPORTING PERSON
     
    IA

     

     
     

     

    CUSIP No. G21810109
     SCHEDULE 13G/A
    Page 3 of 11 Pages
             
    1
    NAME OF REPORTING PERSONS
     
    Generation Investment Management US LLP
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    14,886,542
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    14,886,542
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    14,886,542
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    2.24%
    12
    TYPE OF REPORTING PERSON
     
    IA

     

     
     

     

    CUSIP No. G21810109
     SCHEDULE 13G/A
    Page 4 of 11 Pages
             
    1
    NAME OF REPORTING PERSONS
     
    Generation IM Fund plc
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Ireland
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    9,371,347
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    9,371,347
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    9,371,347
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    1.41%
    12
    TYPE OF REPORTING PERSON
     
    CO

     

     
     

     

    CUSIP No. G21810109
     SCHEDULE 13G/A
    Page 5 of 11 Pages
             
    1
    NAME OF REPORTING PERSONS
     
    Generation IM Global Equity Fund LLC
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a) o
    (b) o
     
    3
    SEC USE ONLY
     
     
    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Delaware
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    0
    6
    SHARED VOTING POWER
     
    8,372,819
    7
    SOLE DISPOSITIVE POWER
     
    0
    8
    SHARED DISPOSITIVE POWER
     
    8,372,819
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    8,372,819
    10
    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
     
     
    o
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    1.26%
    12
    TYPE OF REPORTING PERSON
     
    OO

     

     
     

     

    CUSIP No. G21810109
     SCHEDULE 13G/A
    Page 6 of  11 Pages

     

    Item 1.(a) Name of Issuer

    CLARIVATE PLC

    (b) Address of Issuer’s Principal Executive Offices

    70 St. Mary Axe

    London EC3A 8BE

    United Kingdom

    Item 2.(a) Name of Person Filing

    Generation Investment Management LLP;

    Generation Investment Management US LLP;

    Generation IM Fund plc; and

    Generation IM Global Equity Fund LLC.

    (b) Address of Principal Business Office, or, if none, Residence

    Generation Investment Management LLP: 20 Air Street, 7th floor, London, United Kingdom W1B 5AN.

    Generation Investment Management US LLP: 555 Mission Street, Suite 3400, San Francisco, CA 94105.

    Generation IM Fund plc: Georges Court, 54-62 Townsend Street, Dublin 2, Ireland.

    Generation IM Global Equity Fund LLC: c/o 555 Mission Street, Suite 3400, San Francisco, CA 94105.

    (c) Citizenship

    Generation Investment Management LLP – England and Wales

    Generation Investment Management US LLP - Delaware

    Generation IM Fund plc - Ireland

    Generation IM Global Equity Fund LLC - Delaware

     (d) Title of Class of Securities

    Ordinary Shares, no par value

     (e) CUSIP No.:

    G21810109

     
     

     

    CUSIP No. G21810109
     SCHEDULE 13G/A
    Page 7 of 11 Pages

     

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

      (a) ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
     
      (b) ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
     
      (c) ¨ Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
     
      (d) ¨ Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
     
      (e) ¨ An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
     
      (f) ¨ An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
     
      (g) ¨ A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
     
      (h) ¨ A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
     
      (i) ¨ A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
     
      (j) ¨ A non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J);
     
      (k) ¨ A group, in accordance with §240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:                            
           

     
     

     

    CUSIP No. G21810109
     SCHEDULE 13G/A
    Page 8 of 11 Pages

     

     

    Item 4. Ownership

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    (a) Amount beneficially owned:

    See the response(s) to Item 9 on the attached cover pages.

    (b) Percent of class:

    See the response(s) to Item 11 on the attached cover pages.

    (c) Number of shares as to which the person has:

    (i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover pages.

    (ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover pages.

    (iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover pages.

    (iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover pages.

    Item 5. Ownership of Five Percent or Less of a Class

     

    If this statement is being filed to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following: [X]

    Item 6. Ownership of More Than Five Percent on Behalf of Another Person

     

    Not Applicable

    Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person

     

    Not Applicable

    Item 8. Identification and Classification of Members of the Group

     

    Not Applicable

    Item 9. Notice of Dissolution of Group

     

    Not Applicable

    Item 10. Certification

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     



     
     
    CUSIP No.  G21810109
     SCHEDULE 13G/A
    Page 9 of 11 Pages

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 14, 2024

      

      GENERATION INVESTMENT MANAGEMENT LLP
           
      By:  /s/ Lisa Anderson
        Name:  Lisa Anderson
        Title:  Chief Operating Officer

     

      GENERATION INVESTMENT MANAGEMENT US LLP
     

    By: Generation Investment Management Services LLC

    Its: Partner

           
      By:  /s/ Ghessycka Lucien Bennett
        Name:  Ghessycka Lucien Bennett
        Title:  US Chief Compliance Officer

     

      GENERATION IM FUND PLC
           
      By:  /s/ Flavia Lugangira
        Name:  Flavia Lugangira
        Title:  Director

     

      GENERATION IM GLOBAL EQUITY FUND LLC
           
      By:  /s/ Ghessycka Lucien Bennett
        Name:  Ghessycka Lucien Bennett
        Title:  US Chief Compliance Officer

     

     

     

     



     
     
    CUSIP No.  G21810109
     SCHEDULE 13G/A
    Page 10 of 11 Pages

     

     

    INDEX TO EXHIBITS

     

    Exhibit No.  Exhibit

    99.1               Joint Filing Agreement

     



     
     
    CUSIP No.  G21810109
     SCHEDULE 13G/A
    Page 11 of 11 Pages

     

     

    Exhibit 99.1

     

    The undersigned acknowledge and agree that the foregoing statement on SCHEDULE 13G/A is filed on behalf of each of the undersigned and that all subsequent amendments to such statement on SCHEDULE 13G/A shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other entity or person, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

     

    Dated: February 14, 2024

      GENERATION INVESTMENT MANAGEMENT LLP
           
      By:  /s/ Lisa Anderson
        Name:  Lisa Anderson
        Title:  Chief Operating Officer

     

      GENERATION INVESTMENT MANAGEMENT US LLP
     

    By: Generation Investment Management Services LLC

    Its: Partner

           
      By:  /s/ Ghessycka Lucien Bennett
        Name:  Ghessycka Lucien Bennett
        Title:  US Chief Compliance Officer

     

      GENERATION IM FUND PLC
           
      By:  /s/ Flavia Lugangira
        Name:  Flavia Lugangira
        Title:  Director

     

      GENERATION IM GLOBAL EQUITY FUND LLC
           
      By:  /s/ Ghessycka Lucien Bennett
        Name:  Ghessycka Lucien Bennett
        Title:  US Chief Compliance Officer
    Get the next $CLVT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CLVT

    DatePrice TargetRatingAnalyst
    11/6/2024Outperform → Mkt Perform
    William Blair
    12/15/2023$8.00Equal Weight → Underweight
    Wells Fargo
    10/16/2023$10.00 → $8.50Hold → Buy
    Jefferies
    9/8/2023$8.00 → $7.00Equal Weight → Underweight
    Barclays
    8/25/2023$9.00 → $8.00Outperform → Sector Perform
    RBC Capital Mkts
    8/7/2023$10.00 → $6.00Neutral → Underperform
    BofA Securities
    8/4/2023$15.00 → $8.00Overweight → Equal Weight
    Wells Fargo
    6/13/2023$11.00Outperform
    Oppenheimer
    More analyst ratings

    $CLVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Bomba Jane L Okun was granted 6,686 units of Ordinary Shares and covered exercise/tax liability with 306 units of Ordinary Shares, increasing direct ownership by 3% to 213,670 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      7/2/25 4:27:41 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Snyder Andrew Miles was granted 11,918 units of Ordinary Shares and covered exercise/tax liability with 527 units of Ordinary Shares, increasing direct ownership by 7% to 164,489 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      7/2/25 4:27:30 PM ET
      $CLVT
      EDP Services
      Technology
    • President, IP Samson James Gordon sold $453,000 worth of Ordinary Shares (100,000 units at $4.53), decreasing direct ownership by 7% to 1,271,103 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      7/2/25 4:27:20 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Clarivate downgraded by William Blair

      William Blair downgraded Clarivate from Outperform to Mkt Perform

      11/6/24 8:22:43 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded Clarivate from Equal Weight to Underweight and set a new price target of $8.00

      12/15/23 8:04:33 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate upgraded by Jefferies with a new price target

      Jefferies upgraded Clarivate from Hold to Buy and set a new price target of $8.50 from $10.00 previously

      10/16/23 9:11:50 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Snyder Andrew Miles bought $989,024 worth of Ordinary Shares (237,176 units at $4.17) (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/18/25 4:56:10 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Bomba Jane L Okun bought $200,492 worth of Ordinary Shares (49,750 units at $4.03) (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/14/25 4:14:29 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Pritchett Wendell E. bought $100,114 worth of Ordinary Shares (22,857 units at $4.38), increasing direct ownership by 47% to 71,835 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/5/25 4:17:24 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Clarivate to Report Second Quarter 2025 Results on July 30, 2025

      LONDON, July 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Wednesday, July 30, 2025 to review the results. The webcast is open to all interest

      7/8/25 7:30:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Unveils the 2025 Journal Citation Reports

      50th Anniversary Year Sees Strengthened Focus on Research Integrity LONDON, June 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2025 update to the Journal Citation Reports (JCR). This is the 50th anniversary of the industry-leading annual reports, which provide a comprehensive overview of the world's leading and trusted academic journals, offering academic institutions, researchers, and publishers the ability to gauge journals' trustworthiness and impact. Only journals that have met the rigorous

      6/18/25 3:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Partners with American Library Association to Advocate for U.S. Libraries

      LONDON, June 9, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new milestone in its decades-long partnership with the American Library Association (ALA). Clarivate will be the first sponsor of the ALA Public Supporter Program, which engages the public in supporting libraries and library professionals.   The ALA is the largest library association in the world. It advocates for libraries, library workers, and everyone they serve, from small, rural libraries to the largest library systems in the country.

      6/9/25 3:00:00 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    SEC Filings

    See more
    • Clarivate Plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CLARIVATE PLC (0001764046) (Filer)

      6/2/25 8:45:15 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - CLARIVATE PLC (0001764046) (Filer)

      5/19/25 4:49:39 PM ET
      $CLVT
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Clarivate Plc

      SCHEDULE 13G/A - CLARIVATE PLC (0001764046) (Subject)

      5/14/25 4:29:43 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Financials

    Live finance-specific insights

    See more
    • Clarivate to Report Second Quarter 2025 Results on July 30, 2025

      LONDON, July 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Wednesday, July 30, 2025 to review the results. The webcast is open to all interest

      7/8/25 7:30:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Reports First Quarter 2025 Results

      — Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON, April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. Organic revenues for the first quarter of 2025 increased 0.3%, compared to the first quarter of 202

      4/29/25 6:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate to Report First Quarter 2025 Results on April 29, 2025

      LONDON, April 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter 2025 before the market opens on Tuesday, April 29, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, April 29, 2025 to review the results. The webcast is open to all interested

      4/2/25 8:05:00 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Clarivate Plc

      SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

      12/5/24 10:02:09 AM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form SC 13G filed by Clarivate Plc

      SC 13G - CLARIVATE PLC (0001764046) (Subject)

      11/13/24 4:18:30 PM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

      SC 13D/A - CLARIVATE PLC (0001764046) (Subject)

      3/4/24 9:01:44 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Leadership Updates

    Live Leadership Updates

    See more
    • Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

      Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

      4/26/23 7:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Names Bar Veinstein as President, Academia & Government

      Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader

      4/19/23 7:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director

      Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.

      3/23/23 4:30:00 PM ET
      $CLVT
      $CNTA
      EDP Services
      Technology
      Biotechnology: Pharmaceutical Preparations
      Health Care